Biostatistics in Drug Development
|
Using statistical methods we want to clarify:
- What kind of study design and sample size is needed to get evidence about drug effect?
- Are there differences between our own investigational drug and comparative drug in both efficacy and safety?
- Can we conclude, based on the study results that the drug effect is as expected?
|
Biostatistics is central to the pharmaceutical drug development. Because of this central role biostatistics is strictly supervised and guided by regulatory authorities. Key steps in the non-clinical and clinical studies are definition of study design, estimation of sample size, randomisation, statistical analysis plan, subject classification and finally statistical analysis and reporting of the data.
 |
Biostatisticians are key players in all these steps. At Orion, statistical methods are applied in non-clinical and clinical studies as well as in pharmaceutical applications. |
Updated
Dec 17th 2010